This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA
Book Now
Menu
Book

Mike Webb, Ph.D.
Founder and CEO at Mike Webb Pharma
Speaker

Profile

Mike Webb PhD was the VP of Development Chemistry and Analysis for GSK in the UK and was heavily involved in developing GSK’s oligonucleotide pipeline. Since leaving GSK in 2016 he has been consulting with Big Pharma and Biotechnology companies in the development, analysis and manufacture of therapeutic oligonucleotides from pre-clinical to marketing submission.

Agenda Sessions

  • Workshop Leaders' Welcome and Opening Remarks

    , 9:00am
    View Session

  • Introduction to Therapeutic Oligonucleotides As a New Drug Class

    , 9:05am
    View Session

  • Therapeutic Oligonucleotide Design

    , 9:30am
    View Session

  • Oligonucleotide Manufacture and Control

    , 12:00pm
    View Session

  • Workshop Leader's Welcome and Opening Remarks

    , 1:30pm
    View Session

  • Workshop PM2: Introduction to Analytical Control Strategies for Therapeutic Oligonucleotides

    , 3:30pm
    View Session

At this event

Prev
Next
Fran Wincott, PhD
President
Wincott & Associates, LLC

See Mike at TIDES USA: Oligonucleotide & Peptide Therapeutics

Book Now